bioAffinity Technologies (BIAF) Stock Price, Quote, News & History

Q: What sector and industry does bioAffinity Technologies (BIAF) operate in?

bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

bioAffinity Technologies (BIAF) Stock Price, Quote, News & History

BIAFNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$1.14

-0.03-2.56%

At close: Jan 30, 4:00 PM EST

$1.14

N/A

After Hours: Jan 30, 6:57 PM EST

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$1.15

$1.14

Volume / Avg.

53.60K / 90.20K

Day Range

$1.11 - $1.18

52 Wk Range

1.11 - 46.53

Market Cap

$5.13M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.18%

Days to Cover

Recent bioAffinity Technologies Inc News

Why Did bioAffinity Technologies' Stock Slip In After-Hours Trading After A Big Day Of Gains?

bioAffinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.

Mohd Haider

What's Driving bioAffinity Technologies' Big Pre-Market Surge?

bioAffinity Technologies shares surged over 20% pre-market following a strong third-quarter sales update for its lung cancer diagnostic test.

Mohd Haider

Energy Fuels, Firefly Aerospace And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.45M

Investing Cash Flow (TTM)

-60.57K

Financing Cash Flow (TTM)

15.42M

Free Cash Flow (TTM)

-8.51M

Capital Expenditure (TTM)

-60.57K

Net Change in Cash (TTM)

6.91M

Valuation Metrics

Enterprise Value

-$1.81M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.12

PB Ratio (TTM)

0.59

Earnings Yield % (TTM)

-1192.24%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$1.98

Company Debt

Total Debt

$180.05K

LT Debt

$43.66K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$354.11K

Total Cash

$7.67M

Debt to Equity

0.08

Issuance of Debt (TTM)

-$162.26K

Repayment of Debt (TTM)

-$354.11K

Key Statistics

Open

$1.15

$1.14

Volume / Avg.

53.60K / 90.20K

Day Range

$1.11 - $1.18

52 Wk Range

1.11 - 46.53

Market Cap

$5.13M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.18%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy bioAffinity Technologies (BIAF) stock?

You can purchase shares of bioAffinity Technologies (NASDAQ:BIAF) through any online brokerage.

View our list of the best stock brokerages

Who are bioAffinity Technologies (BIAF) competitors?

Other companies in bioAffinity Technologies’s space includes: Immuron Ltd (NASDAQ:IMRN), Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Can Fite Biopharma Ltd (AMEX:CANF), Geovax Labs Inc (NASDAQ:GOVX) and Genprex Inc (NASDAQ:GNPX).

What is the forecast, or price target, for bioAffinity Technologies (BIAF) stock?

There is no analysis for bioAffinity Technologies to provide a consensus price target.

What is the current price for bioAffinity Technologies (BIAF)?

The stock price for bioAffinity Technologies (NASDAQ: BIAF) is $1.14 last updated January 30, 2026 at 6:57 PM EST.

Does bioAffinity Technologies (BIAF) pay a dividend?

There are no upcoming dividends for bioAffinity Technologies.

When is bioAffinity Technologies (NASDAQ:BIAF) reporting earnings?

bioAffinity Technologies does not have any upcoming earnings scheduled.

Is bioAffinity Technologies (BIAF) going to split?

There is no upcoming split for bioAffinity Technologies.

What sector and industry does bioAffinity Technologies (BIAF) operate in?

bioAffinity Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Acurx Pharmaceuticals Inc

NASDAQ:ACXP

$2.46

4.02%

Can Fite Biopharma Ltd

AquaBounty Technologies Inc

NASDAQ:AQB

$0.97

7.12%

Indaptus Therapeutics Inc

NASDAQ:INDP

$2.24

1.92%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$1.15

$1.14

Volume / Avg.

53.60K / 90.20K

Day Range

$1.11 - $1.18

52 Wk Range

1.11 - 46.53

Market Cap

$5.13M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.18%

Days to Cover

Recent bioAffinity Technologies Inc News

Why Did bioAffinity Technologies' Stock Slip In After-Hours Trading After A Big Day Of Gains?

bioAffinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.

Mohd Haider

What's Driving bioAffinity Technologies' Big Pre-Market Surge?

bioAffinity Technologies shares surged over 20% pre-market following a strong third-quarter sales update for its lung cancer diagnostic test.

Mohd Haider

Energy Fuels, Firefly Aerospace And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.45M

Investing Cash Flow (TTM)

-60.57K

Financing Cash Flow (TTM)

15.42M

Free Cash Flow (TTM)

-8.51M

Capital Expenditure (TTM)

-60.57K

Net Change in Cash (TTM)

6.91M

Valuation Metrics

Enterprise Value

-$1.81M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.12

PB Ratio (TTM)

0.59

Earnings Yield % (TTM)

-1192.24%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$1.98

Company Debt

Total Debt

$180.05K

LT Debt

$43.66K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$354.11K

Total Cash

$7.67M

Debt to Equity

0.08

Issuance of Debt (TTM)

-$162.26K

Repayment of Debt (TTM)

-$354.11K

Key Statistics

Open

$1.15

$1.14

Volume / Avg.

53.60K / 90.20K

Day Range

$1.11 - $1.18

52 Wk Range

1.11 - 46.53

Market Cap

$5.13M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

1.18%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry